Axon Neuroscience's active tau immunotherapy AADvac1 has been selected as the first tau-targeted therapy to enter a ...

A new study found that a combination of hormone therapy and the GLP-1 medication tirzepatide (Zepbound) led to 35% more ...

In recent years, research into cannabis and its main psychoactive ingredient, Δ⁹-tetrahydrocannabinol (THC), has unearthed ...

Skin and soft tissue infections are more common in children with Crohn’s disease, especially those receiving combination ...

The FDA is reviewing zanzalintinib combined with atezolizumab for metastatic colorectal cancer, with a PDUFA target date of December 3, 2026. The STELLAR-303 trial showed significant overall survival ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

European regulators recommend a novel checkpoint inhibitor and antibody-drug conjugate combination for young patients with ...

Spanish scientists have created a new triple drug therapy that completely cures pancreatic cancer in mice. This experimental ...

Patients with early-stage Hodgkin lymphoma had impressive response rates when treated with a novel combination of ...

According to CNIO, among the various kinds of cancer, pancreatic cancer remains one of the deadliest and is a widely known tumor at a molecular level, with an immensely low survival rate.

Combination therapies represent a promising frontier in cancer treatment, addressing the critical need to enhance efficacy ...